Evidence mapPaperPMID 40407708Full record

ArticleInteractive journal of medical research2025

Systemic Inflammation and Disruption of the Local Microenvironment Compromise Muscle Regeneration: Critical Pathogenesis of Autoimmune-Associated Sarcopenia.

Yingjuan Zhang, Qingqian Wu, Yi Wang, Qingyan Chen, Shuang Han, Bei Li, Qingwen Zhao, Qianzhuo Wang, Yule Wang, Yue Gao

Abstract read
In one paragraph

Article in Interactive journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yingjuan Zhang *Department of Geriatrics, Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, Shangcheng District, Hangzhou, 310006, China, 86 13706511908.ORCID http://orcid.org/0009-0000-7747-2266
Qingqian Wu *Department of Geriatrics, Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, Shangcheng District, Hangzhou, 310006, China, 86 13706511908.ORCID http://orcid.org/0000-0001-7392-8801
Yi Wang *Yixing Center for Disease Control and Prevention, Yixing, Jiangsu Province, China.ORCID http://orcid.org/0009-0000-3298-986X
Qingyan ChenFourth Clinical School of Medicine, Zhejiang Chinese Medical University, Hangzhou, China.ORCID http://orcid.org/0009-0006-4517-5228
Shuang HanDepartment of Geriatrics, Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, Shangcheng District, Hangzhou, 310006, China, 86 13706511908.ORCID http://orcid.org/0000-0001-9736-0093
Bei LiDepartment of Geriatrics, Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, Shangcheng District, Hangzhou, 310006, China, 86 13706511908.ORCID http://orcid.org/0000-0003-1885-076X
Qingwen ZhaoDepartment of Geriatrics, Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, Shangcheng District, Hangzhou, 310006, China, 86 13706511908.ORCID http://orcid.org/0000-0003-3318-6545
Qianzhuo WangDepartment of Geriatrics, Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, Shangcheng District, Hangzhou, 310006, China, 86 13706511908.ORCID http://orcid.org/0009-0005-5615-2550
Yule WangDepartment of Geriatrics, Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, Shangcheng District, Hangzhou, 310006, China, 86 13706511908.ORCID http://orcid.org/0000-0003-1079-8231
Yue GaoDepartment of Geriatrics, Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, Shangcheng District, Hangzhou, 310006, China, 86 13706511908.ORCID http://orcid.org/0000-0003-4541-4015

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: Sarcopenia is defined by age-related reductions in muscle mass, strength, and physiological function, and it is especially prevalent among individuals with autoimmune diseases. Autoimmune disorders, characterized by immune dysregulation, cause systemic inflammation and damage to multiple tissues through unregulated immune activity. Research indicates that autoimmune diseases negatively impact skeletal muscle functions and may worsen the progression of sarcopenia. This viewpoint comprehensively discusses the pathogenesis and potential mechanism of sarcopenia in 3 autoimmune diseases: inflammatory bowel disease, rheumatoid arthritis, and type 1 diabetes mellitus. Mechanistically, chronic immune microenvironment alterations induce compartment-specific redistribution of leukocyte subsets and cytokine networks. These perturbations disrupt critical signaling pathways governing muscle protein synthesis, satellite cell activation, and mitochondrial bioenergetics, leading to impaired regeneration and accelerated sarcopenia progression. By delineating shared and distinct pathomechanisms across these models, this analysis reframes our understanding of immune-mediated muscle wasting. Beyond mechanistic insights, it establishes a translational framework for targeted therapies and highlights emerging research directions bridging immunology and age-related musculoskeletal decline.

Indexed as

immune diseasesinflammatory bowel diseaserheumatoid arthritissarcopeniatype 1 diabetes mellitus

Identifiers

PMID40407708
PMCPMC12124038

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.